Global Endoscopic Ultrasound Market Size to Reach $2.2 Billion by 2031: AMR

Portland, OR, Oct. 04, 2022 (GLOBE NEWSWIRE) -- A new business intelligence report released by Allied Market Research, the global Endoscopic Ultrasound (EUS) Market size generated $1.2 billion in 2021, and is expected to reach $2.2 billion by 2031, witnessing a CAGR of 6.1% from 2022 to 2031. The report offers an in-depth analysis of changing market trends, top segments, value chain, and competitive landscape. This report provides detailed information to assist market players, stakeholders, investors, and startups in devising strategies for gaining sustainable growth and availing competitive advantage in the market.

Download Free Sample Report (300 Pages PDF with Insights, Charts, Tables, Figures): https://www.alliedmarketresearch.com/request-sample/18050

Report coverage & details:

Covid-19 Scenario:

• The Covid-19 pandemic made a negative impact on the growth of the endoscopic ultrasound (EUS) market, owing to delay in non-urgent procedures with rise in focus on treatment of patients suffering from Covid-19 infection. Many treatments that did not need urgent attention were postponed to take care of Covid-infected patients.
• The Covid-19 pandemic presented difficulties for the pharmaceutical industry as there were disruptions in R&D activities including endoscopic ultrasound (EUS). This, in turn, impacted the overall revenue of the market.
• However, the demand for endoscopic ultrasound is expected to recover post-pandemic as regular visits to hospitals and clinics begin as vaccinations begin and the possibility of cross contamination also reduce.
• The R&D activities were affected during the pandemic due to disruptions in operations of research and healthcare institutions. The pace of development of technologically-advanced devices reduced. However, it will gain traction post-pandemic.

The research provides detailed segmentation of the global endoscopic ultrasound (EUS) market based on product, application, end user, and region. The report offers a detailed analysis of segments and sub-segments to determine the highest revenue-generating and highest-growing segments for market players and investors. Market size and forecasts are provided for segments and their sub-segments in the report to outline the steps taken for achieving the sustainable growth.

Purchase Inquiry:
https://www.alliedmarketresearch.com/purchase-enquiry/18050

Based on product, the endoscopes segment accounted for the highest share in 2021, contributing to more than one-fourth of the total share, and is estimated to maintain its leadership status during the forecast period. However, the needles segment is expected to manifest the highest CAGR of 6.8% from 2022 to 2031. The report also analyzes the segments including ultrasound probes, ultrasonic processors, imaging system, and accessories.

Based on application, the pancreatic conditions segment held the highest share in 2021, accounting for nearly more than half of the global endoscopic ultrasound (EUS) market, and is estimated to maintain its lead position during the forecast period. However, the oncology segment is expected to manifest the highest CAGR of 6.8% from 2022 to 2031.

Based on end user, the hospitals segment contributed to the highest share in 2021, holding nearly three-fifths of the total market share, and is expected to maintain its dominance in terms of revenue by 2031. However, the ambulatory surgery centers and clinics segment is projected to register the highest CAGR of 6.3% during the forecast period.

Based on region, North America held the highest share in 2021, contributing to more than one-third of the global endoscopic ultrasound market, and is expected to continue its dominance by 2031. However, Asia-Pacific is projected to grow at the fastest CAGR of 7.1% during the forecast period. The research also analyzes regions including Europe and LAMEA.

The research provides detailed analysis of leading players of the global endoscopic ultrasound (EUS) market. Key players analyzed in the research include Boston Scientific Corporation, Cook Medical, CONMED Corporation, Medtronic, Inc., Limaca Medical, Pentax Medical, Olympus Medical, Sonoscape Medical Corp., Smith & Nephew plc, and Stryker Corporation. The report analyzes these key players based on various parameters such as product portfolio, operating segments, business performance, and key developments and outlines different strategies such as expansion, partnerships, new product launches, and others adopted by them to raise their market penetration and consolidate the position in the global market.

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

IVF Market in U.S. By Cycle Type (Fresh IVF Cycle, Thawed IVF Cycle and Donor egg IVF cycle) and End User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes): Analysis and Industry Forecast, 2019-2027

Electrocardiograph (ECG) Market By Product (Resting Electrocardiograph (ECG), Stress Electrocardiograph (ECG), Holter Monitors, Others), By End User (Hospitals & Clinics, Home Settings & Ambulatory Surgical Centers (ASCs), Others), By Lead Type (Single Lead ECG, 2 Lead ECG, 3 Lead ECG, 6 Lead ECG, 12-Lead ECG): Global Opportunity Analysis and Industry Forecast, 2020-2030

Mass Spectrometry Market by Technology (Hybrid Mass Spectrometry [Triple Quadrapole, Quadrapole TOF, and Fourier Transform Mass Spectrometry], Single Mass Spectrometry [Ion Trap, Quadrapole, and Time-of-Flight], and Other Mass Spectrometry) and Application (Pharmaceutical, Biotechnology, Security, Industrial Chemistry, Environmental Testing, Food & Beverage Testing, Forensic, Clinical and Other Applications): Global Opportunity Analysis and Industry Forecast, 2021-2030

Cancer Gene Therapy Market by Therapy (Gene Induced Immunotherapy, Oncolytic Virotherapy, Gene Transfer), by End User (Hospitals, Diagnostic centers, Research Institutes): Global Opportunity Analysis and Industry Forecast, 2020-2030

Immunoglobulin Market by Application (Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy, Immunodeficiency Disease, Myasthenia Gravis, Multifocal Motor Neuropathy, Idiopathic Thrombocytopenic Purpura, Inflammatory Myopathies, Specific Antibody Deficiency, Guillain-Barre Syndrome, and Others), Product Type (IgG, IgA, IgM, IgE, and IgD), and by Mode of Delivery (Intravenous and Subcutaneous): Global Opportunity Analysis and Industry Forecast, 2018 - 2025

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Follow Us on Blog: https://www.globalhealthcareindustry.com/